Literature DB >> 16075461

Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.

Rebecca R Selzer1, Todd A Richmond, Nathan J Pofahl, Roland D Green, Peggy S Eis, Prakash Nair, Arthur R Brothman, Raymond L Stallings.   

Abstract

Understanding the genes and genetic pathways targeted by recurrent chromosomal imbalances in malignancy, along with the molecular mechanisms that generate the imbalances, are important problems in cancer biology. In this report, we demonstrate that oligonucleotide array CGH (oaCGH) analysis can routinely map chromosomal imbalance breakpoints at exon-level resolution, including imbalances that are single copy number genomic alterations. Different tiling-path array designs were used in this study: a whole-genome array with a 6-kb median probe spacing and fine-tiling arrays for selected genomic regions with either 50- or 140-bp median probe spacing. In both array formats, oligonucleotide probes were of isothermal design and were tiled through genic and inter-genic regions. Whole-genome oaCGH analysis of two neuroblastoma cell lines and three primary tumors led to the identification of 58 chromosomal breakpoints that generated 45 large-scale partial chromosomal imbalances (> 2 Mb). An unexpectedly high proportion (34%) of these breakpoint intervals mapped to regions containing segmental duplications. In addition, 88 smaller-sized regions (< 2 Mb) of imbalance were detected, the majority of which mapped to segmentally duplicated regions and may reflect constitutional copy number polymorphisms. The chromosomal breakpoints for 12 recurrent abnormalities exhibited in neuroblastoma tumors and cell lines, including MYCN amplicon boundaries, loss of 3p, loss of 11q, and gain of 17q, could be mapped to intervals ranging from 50 bp to 10 kb in size using high-density fine-tiling oligonucleotide microarrays. Fine-tiling oaCGH analysis provides an unprecedented level of resolution, allowing detailed mapping of recurrent unbalanced chromosomal abnormalities. Supplementary material for this article can be found on the Genes, Chromosomes, and Cancer website at http://www.interscience.wiley.com/jpages/1045-2257/suppmat/index.html. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16075461     DOI: 10.1002/gcc.20243

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  128 in total

1.  Serial translocation by means of circular intermediates underlies colour sidedness in cattle.

Authors:  Keith Durkin; Wouter Coppieters; Cord Drögemüller; Naima Ahariz; Nadine Cambisano; Tom Druet; Corinne Fasquelle; Aynalem Haile; Petr Horin; Lusheng Huang; Yohichiro Kamatani; Latifa Karim; Mark Lathrop; Simon Moser; Kor Oldenbroek; Stefan Rieder; Arnaud Sartelet; Johann Sölkner; Hans Stålhammar; Diana Zelenika; Zhiyan Zhang; Tosso Leeb; Michel Georges; Carole Charlier
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

2.  Late-replicating heterochromatin is characterized by decreased cytosine methylation in the human genome.

Authors:  Masako Suzuki; Mayumi Oda; María-Paz Ramos; Marién Pascual; Kevin Lau; Edyta Stasiek; Frederick Agyiri; Reid F Thompson; Jacob L Glass; Qiang Jing; Richard Sandstrom; Melissa J Fazzari; R Scott Hansen; John A Stamatoyannopoulos; Andrew S McLellan; John M Greally
Journal:  Genome Res       Date:  2011-09-28       Impact factor: 9.043

3.  Broad chromosomal domains of histone modification patterns in C. elegans.

Authors:  Tao Liu; Andreas Rechtsteiner; Thea A Egelhofer; Anne Vielle; Isabel Latorre; Ming-Sin Cheung; Sevinc Ercan; Kohta Ikegami; Morten Jensen; Paulina Kolasinska-Zwierz; Heidi Rosenbaum; Hyunjin Shin; Scott Taing; Teruaki Takasaki; A Leonardo Iniguez; Arshad Desai; Abby F Dernburg; Hiroshi Kimura; Jason D Lieb; Julie Ahringer; Susan Strome; X Shirley Liu
Journal:  Genome Res       Date:  2010-12-22       Impact factor: 9.043

4.  Genome-wide polymorphisms and development of a microarray platform to detect genetic variations in Plasmodium yoelii.

Authors:  Sethu C Nair; Sittiporn Pattaradilokrat; Martine M Zilversmit; Jennifer Dommer; Vijayaraj Nagarajan; Melissa T Stephens; Wenming Xiao; John C Tan; Xin-Zhuan Su
Journal:  Mol Biochem Parasitol       Date:  2014-03-29       Impact factor: 1.759

5.  Recurrent genomic imbalances in primary effusion lymphomas.

Authors:  Prakash Nair; Hongyi Pan; Raymond L Stallings; Shou-Jiang Gao
Journal:  Cancer Genet Cytogenet       Date:  2006-12

6.  Ultra-high resolution array painting facilitates breakpoint sequencing.

Authors:  S M Gribble; D Kalaitzopoulos; D C Burford; E Prigmore; R R Selzer; B L Ng; N S W Matthews; K M Porter; R Curley; S J Lindsay; J Baptista; T A Richmond; N P Carter
Journal:  J Med Genet       Date:  2006-09-13       Impact factor: 6.318

7.  Comparative isoschizomer profiling of cytosine methylation: the HELP assay.

Authors:  Batbayar Khulan; Reid F Thompson; Kenny Ye; Melissa J Fazzari; Masako Suzuki; Edyta Stasiek; Maria E Figueroa; Jacob L Glass; Quan Chen; Cristina Montagna; Eli Hatchwell; Rebecca R Selzer; Todd A Richmond; Roland D Green; Ari Melnick; John M Greally
Journal:  Genome Res       Date:  2006-06-29       Impact factor: 9.043

Review 8.  Genomic platforms for cancer research: potential diagnostic and prognostic applications in clinical oncology.

Authors:  Pedro Jares; Elías Campo
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

9.  Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

Authors:  Katharina Steinmann; David N Cooper; Lan Kluwe; Nadia A Chuzhanova; Cornelia Senger; Eduard Serra; Conxi Lazaro; Montserrat Gilaberte; Katharina Wimmer; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

10.  A new chromosome x exon-specific microarray platform for screening of patients with X-linked disorders.

Authors:  Stavros Bashiardes; Ludmila Kousoulidou; Hans van Bokhoven; Hans-Hilger Ropers; Jamel Chelly; Claude Moraine; Arjan P M de Brouwer; Hilde Van Esch; Guy Froyen; Philippos C Patsalis
Journal:  J Mol Diagn       Date:  2009-09-24       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.